Siro Clinpharm Private Limited

Siro Clinpharm Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN U24230MH2000PTC125061 Incorporated 21 March 2000 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹40.18 Cr
▲ 13.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹25 Cr
Registered with MCA
Paid-up capital
₹6.1 Lakh
Issued & subscribed
Open charges
₹5.16 Cr
Satisfied ₹119.93 Cr
Company age
26 yrs
Est. 2000
Employees · EPFO
258
Latest available

About Siro Clinpharm Private Limited

Data last updated: 22 December 2025

Siro Clinpharm Private Limited is a private limited company based in Mumbai, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 21 March 2000, the company has been in operation for over 26 years.

Registered with ROC Mumbai under CIN U24230MH2000PTC125061.

Capital: an authorised share capital of ₹25 Cr and a paid-up capital of ₹6.1 Lakh. It is led by directors including Akshay Gautam Daftary and Karan Gautam Daftary.

Last AGM: 31 December 2024. Financial statements filed for year ended 31 March 2024. Office: 16Th Floor Hoechst House Nariman Point Mumbai, Mumbai City Mh 400021, Maharashtra, India – 400021.

As per the financials filed for FY 2025, the company reported a revenue of ₹40.18 Cr, a growth of 13% compared to the previous year.

The company has a workforce of approximately 258 employees as per the latest available data.

The company is associated with 1 brand - Siro Clinpharm. As per MCA filings, the company has open charges of ₹5.16 Cr and satisfied charges of ₹119.93 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website siroclinpharm.com.

Company Details of Siro Clinpharm Private Limited
CIN U24230MH2000PTC125061
Registration Number 125061
Incorporation Date 21 March 2000
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 December 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    16Th Floor Hoechst House Nariman Point Mumbai, Mumbai City Mh 400021, Maharashtra, India – 400021
  • Industry
    Pharma, Drug Formulation & Development
Company report
Siro Clinpharm Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Siro Clinpharm Private Limited report

Financials, compliance, directors, charges, ownership and filings for Siro Clinpharm Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Siro Clinpharm Private Limited

Siro Clinpharm Private Limited operates one associated brand: Siro Clinpharm. These brands represent Siro Clinpharm Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Clinical development services are offered to the global healthcare industry. siroclinpharm.com

Competitors & Alternatives of Siro Clinpharm Private Limited

Brands and companies operating in the same space as Siro Clinpharm Private Limited include Emmes, Syneos Health, ClinChoice and 5 more.

Competitor Description Location Founded
Emmes Emmes Outsourced contract research organization services are provided to clients. United States 1977
Syneos Health Syneos Health CRO clinical development services are provided by Syneos Health. Raleigh, United States, United States 1984
ClinChoice ClinChoice CRO focused on data management, regulatory affairs and consulting services Fort Washington, United States, United States 1995
Veristat Veristat Clinical trials and regulatory submissions are supported as a CRO. Southborough, United States, United States 1994
Parexel Parexel Full-service clinical research organization services are provided globally by Parexel. Waltham, United States, United States 1983
Medelis WCCT Global Medelis WCCT Global Full-service CRO expertise in influenza and oncology research is offered. Cypress, United States, United States 1998
Celgene Celgene Therapies for cancer and inflammatory diseases are developed. Summit, United States, United States 1986
PRA Health Sciences PRA Health Sciences Global full-service CRO services are delivered in over 80 countries. Raleigh, United States, United States 1976

Auditor Details of Siro Clinpharm Private Limited

Siro Clinpharm Private Limited is audited by Deloitte Haskins & Sells LLP for the financial year 2022. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
Deloitte Haskins & Sells LLP Locked Locked Locked
Premium access

Complete auditor history for Siro Clinpharm Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Siro Clinpharm Private Limited

Siro Clinpharm Private Limited is currently managed by 3 directors, with 17 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Akshay Gautam Daftary Director 12 Feb 2018 8 Years 6 Months Current
Karan Gautam Daftary Whole-Time Director 12 Sep 2018 7 Years 11 Months Current
Gautam Vinod Daftary Director 21 Mar 2000 26 Years 4 Months Current

Financials of Siro Clinpharm Private Limited FY 2024 filings available

Siro Clinpharm Private Limited reported revenue of ₹40.18 Cr (up 13.00% YoY) for FY 2025.

Revenue · FY 2025
₹40.18 Cr ▲ 13.00%
Premium access

Ten-year financial statements for Siro Clinpharm Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Siro Clinpharm Private Limited

Premium access

Shareholding and ownership data for Siro Clinpharm Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Siro Clinpharm Private Limited

Open charges
₹5.16 Cr
Satisfied charges
₹119.93 Cr
Breakdown by lending institutions
Others₹5.16 Cr
Latest charge details
DateLenderAmountStatus
30 Dec 2024 Others ₹1.5 Cr Open
16 Oct 2024 Others ₹1.29 Cr Open
27 Mar 2024 Others ₹1.37 Cr Open
24 Nov 2021 Others ₹1 Cr Open
12 Mar 2019 Others ₹4.5 Cr Satisfied

Total charge records: 17 View all charges

Employees and EPFO Compliance at Siro Clinpharm Private Limited

Siro Clinpharm Private Limited has a workforce of 258 employees as of Mar 22, 2024.

Employee count
258
Active EPFO establishments
1
Employee growth
-1.53%
Premium access

Employee and EPFO history for Siro Clinpharm Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Siro Clinpharm Private Limited

Premium access

GST registrations and filing compliance for Siro Clinpharm Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Siro Clinpharm Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Siro Clinpharm Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Siro Clinpharm Private Limited

Premium access

MSME payment history for Siro Clinpharm Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Siro Clinpharm Private Limited

Premium access

Corporate group structure for Siro Clinpharm Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Siro Clinpharm Private Limited

Premium access

MCA filings and documents for Siro Clinpharm Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Siro Clinpharm Private Limited

Activity
31 Dec 2024
Siro Clinpharm Private Limited last Annual general meeting of members was held on 31 Dec 2024 as per latest MCA records.
Charges
30 Dec 2024
A charge with Others amounted to Rs. 1.50 Cr with Charge ID 101035220 was registered on 30 Dec 2024.
Charges
16 Oct 2024
A charge with Others amounted to Rs. 1.29 Cr with Charge ID 100995543 was registered on 16 Oct 2024.
Activity
31 Mar 2024
Siro Clinpharm Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
27 Mar 2024
A charge with Others amounted to Rs. 1.37 Cr with Charge ID 100910202 was registered on 27 Mar 2024.
Charges
24 Nov 2021
A charge with Others amounted to Rs. 1.00 Cr with Charge ID 100517853 was registered on 24 Nov 2021.

Recent News on Siro Clinpharm Private Limited

Frequently Asked Questions about Siro Clinpharm Private Limited

Siro Clinpharm Private Limited is an active private limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 21 March 2000 (26+ years old) and is registered under CIN U24230MH2000PTC125061. The company has 258 employees.

Siro Clinpharm Private Limited reported revenue of ₹40.18 Cr for FY 2025 (up 13.00% YoY).

The current directors of Siro Clinpharm Private Limited are:

The primary industry of Siro Clinpharm Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Siro Clinpharm Private Limited can be reached at the registered office: 16Th Floor Hoechst House Nariman Point Mumbai, Mumbai City Mh 400021, Maharashtra, India – 400021, or through the website siroclinpharm.com.

The authorised capital is ₹25 Cr, and the paid-up capital is ₹6.1 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available